Patient satisfaction is about the Total Quality of the Patient Encounter (TQE). TQE is the sum of Patient Experience (as defined by CMS) plus Patient Satisfaction as defined by all of the non CMS related touchpoints.
Patient satisfaction is about the Total Quality of the Patient Encounter (TQE). TQE is the sum of Patient Experience (as defined by CMS) plus Patient Satisfaction as defined by all of the non CMS related touchpoints.
Build Physician Relationships that Drive Business Results; Part 1Renown Health
Baystate Health has established a comprehensive, data-driven approach to cultivate new physician referrals, retain current business and earn trust. Learn how market intelligence, business analytics and customer experience design are used to focus physician outreach efforts and drive bottom line results.
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HxRefactored
As tracking has become more mainstream, consumers who were once only curious about their heart rate at the gym are now interested in diving deeper and learning more. This session takes a look at the technical side of the latest in telehealth solutions, genomic platforms, and hacks in the world of sensors and devices.
B. McLaughlin Associates, Inc. (BMA) has been a provider of customized, cost-effective clinical research support for over 18 years. Our services for drug, biologics, and device studies include Study Management, Regulatory and Financial Document Collection and Review, Regulatory Document Audits, Clinical Study Contract/Patient Budget Negotiation, Informed Consent Creation, Review and Change Management, Drug and Biologics Temperature Monitoring (Cold Chain), Data Management, and Clinical Scientist Support.
We recognize the importance of a successfully run clinical trial and have the industry experienced staff to enhance your study team and create positive results. Our Study Analysts, Data Analysts, and Study Managers will professionally run your projects to ensure timely completion of all contracted tasks, while keeping quality, accountability, and compliance paramount. Whether your outsourcing requirements are for the full life cycle of a clinical trial or just for a specific need, BMA is here to provide a flexible solution.
Our goal is to provide world class support services that keep your projects on time, within budget, and compliant to all regulatory authorities.
Christina Walters, Programme Director and Andrew Barber, Technical Consultant, Community Indicators Programme.
Commissioning for outcomes is regarded as good practice.
Christina explores a process for developing outcomes for commissioners and share the work being undertaken nationally to develop standard outcomes for services.
Dr Christina Walters, Programme Director, Community Indicators Programme.
Christina Walters is an independent consultant to the health care sector, through her company Hazel Health Consulting Ltd. The consultancy provides strategic insight and solutions to mental health and community health care providers, and their commissioners; currently facing challenges in developing and implementing quality indicators and outcome measures, clinical currencies and the national mental health payment system programme.
Christina is the Programme Director of ‘Demonstrating the Value of Community Services’ - the national programme to develop quality indicators in community services, and is involved in developing national work on payment systems in community services. From 2012 until 2014, Christina was an Associate Director at the NHS Confederation, for the community services sector.
After a research science career in Microbiology and Immunology and gaining a PhD in 1998, Christina joined the NHS. From 2007 onwards she developed the mental health care clusters, care packages and pathways and supported the national work development of PbR for mental health.
Andrew Barber, Technical Consultant, Community Indicators Programme
Andrew is an experienced individual having worked in both the public and private sector. His most recent career in the NHS has included performance improvement and information management roles with an aspirant community foundation trust. Previously, he has worked in performance improvement, planning and information management roles at a strategic health authority and three acute hospitals. In the private sector, working with PricewaterhouseCoopers, he gained significant experience undertaking performance audit and consultancy work for health and local government organisations. Andrew is also co-chair of the NHS Benchmarking Network.
Compliatric continuous compliance series chapter 5Compliatric
As Operational Site Visits (OSVs) resume virtually, it is important for Community Health Centers to maintain continuous compliance. Compliatric is excited to continue their “Compliance Webinar Series” where each month, program requirements are reviewed to assist health centers in understanding various elements. Participants will be able to utilize these webinars to increase their knowledge of the requirements, and also take compliance to the next level.
This month’s webinar will focus on the following chapter:
Chapter 5: Clinical Staffing
Webinar attendee takeaways will include:
· Understanding the requirements and why they are important
· Methods to maintain continuous compliance (without addressing it last minute or only during an OSV)
· How to use the requirement in everyday practice to improve your Community Health Center
San Francisco Bay Area: Top 10 Radiology Clinics & Imaging Centers in 2018GCRclinics
For more information, check the full version of report - http://blog.gcr.org/san-francisco-ba…ing-centers-2018/
According to the GCR's latest analysis of Radiology Clinics & Imaging Centers in San Francisco Bay Area, Stanford Health Care (Radiology) ranks as the leading clinic in San Francisco Bay Area, when it comes to overall international clinic reputation. A total of 220 Radiology Clinics & Imaging Centers were included in the study. The average GCR clinic quality score was 3.22.
Stanford Health Care (Radiology) ranked #1 with a GCR Score of 4.24, and ranks #1 from 10,816 Radiology clinics & hospitals monitored worldwide, followed by Palo Alto Medical Foundation - Radiology (3.89) and the Washington Hospital - Ultrasound Imaging (3.73).
CloseCareGap is an approved Patient Safety Organization (PSO). Using the award winning clinicalMessage ePlatform, staff can use smart tools to help measure best practice and reduce variations in care delivery at the bedside. The basic PSO toolkit is FREE and can be implemented with a few short clicks via a secure online portal. We have adopted the “IHI Leadership, Support and Care Processes” as critical areas to focus on closing gaps in care using a Continuous Learning Improvement Platform. For more information, go to http://www.clinicalmessage.org
Build Physician Relationships that Drive Business Results; Part 1Renown Health
Baystate Health has established a comprehensive, data-driven approach to cultivate new physician referrals, retain current business and earn trust. Learn how market intelligence, business analytics and customer experience design are used to focus physician outreach efforts and drive bottom line results.
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HxRefactored
As tracking has become more mainstream, consumers who were once only curious about their heart rate at the gym are now interested in diving deeper and learning more. This session takes a look at the technical side of the latest in telehealth solutions, genomic platforms, and hacks in the world of sensors and devices.
B. McLaughlin Associates, Inc. (BMA) has been a provider of customized, cost-effective clinical research support for over 18 years. Our services for drug, biologics, and device studies include Study Management, Regulatory and Financial Document Collection and Review, Regulatory Document Audits, Clinical Study Contract/Patient Budget Negotiation, Informed Consent Creation, Review and Change Management, Drug and Biologics Temperature Monitoring (Cold Chain), Data Management, and Clinical Scientist Support.
We recognize the importance of a successfully run clinical trial and have the industry experienced staff to enhance your study team and create positive results. Our Study Analysts, Data Analysts, and Study Managers will professionally run your projects to ensure timely completion of all contracted tasks, while keeping quality, accountability, and compliance paramount. Whether your outsourcing requirements are for the full life cycle of a clinical trial or just for a specific need, BMA is here to provide a flexible solution.
Our goal is to provide world class support services that keep your projects on time, within budget, and compliant to all regulatory authorities.
Christina Walters, Programme Director and Andrew Barber, Technical Consultant, Community Indicators Programme.
Commissioning for outcomes is regarded as good practice.
Christina explores a process for developing outcomes for commissioners and share the work being undertaken nationally to develop standard outcomes for services.
Dr Christina Walters, Programme Director, Community Indicators Programme.
Christina Walters is an independent consultant to the health care sector, through her company Hazel Health Consulting Ltd. The consultancy provides strategic insight and solutions to mental health and community health care providers, and their commissioners; currently facing challenges in developing and implementing quality indicators and outcome measures, clinical currencies and the national mental health payment system programme.
Christina is the Programme Director of ‘Demonstrating the Value of Community Services’ - the national programme to develop quality indicators in community services, and is involved in developing national work on payment systems in community services. From 2012 until 2014, Christina was an Associate Director at the NHS Confederation, for the community services sector.
After a research science career in Microbiology and Immunology and gaining a PhD in 1998, Christina joined the NHS. From 2007 onwards she developed the mental health care clusters, care packages and pathways and supported the national work development of PbR for mental health.
Andrew Barber, Technical Consultant, Community Indicators Programme
Andrew is an experienced individual having worked in both the public and private sector. His most recent career in the NHS has included performance improvement and information management roles with an aspirant community foundation trust. Previously, he has worked in performance improvement, planning and information management roles at a strategic health authority and three acute hospitals. In the private sector, working with PricewaterhouseCoopers, he gained significant experience undertaking performance audit and consultancy work for health and local government organisations. Andrew is also co-chair of the NHS Benchmarking Network.
Compliatric continuous compliance series chapter 5Compliatric
As Operational Site Visits (OSVs) resume virtually, it is important for Community Health Centers to maintain continuous compliance. Compliatric is excited to continue their “Compliance Webinar Series” where each month, program requirements are reviewed to assist health centers in understanding various elements. Participants will be able to utilize these webinars to increase their knowledge of the requirements, and also take compliance to the next level.
This month’s webinar will focus on the following chapter:
Chapter 5: Clinical Staffing
Webinar attendee takeaways will include:
· Understanding the requirements and why they are important
· Methods to maintain continuous compliance (without addressing it last minute or only during an OSV)
· How to use the requirement in everyday practice to improve your Community Health Center
San Francisco Bay Area: Top 10 Radiology Clinics & Imaging Centers in 2018GCRclinics
For more information, check the full version of report - http://blog.gcr.org/san-francisco-ba…ing-centers-2018/
According to the GCR's latest analysis of Radiology Clinics & Imaging Centers in San Francisco Bay Area, Stanford Health Care (Radiology) ranks as the leading clinic in San Francisco Bay Area, when it comes to overall international clinic reputation. A total of 220 Radiology Clinics & Imaging Centers were included in the study. The average GCR clinic quality score was 3.22.
Stanford Health Care (Radiology) ranked #1 with a GCR Score of 4.24, and ranks #1 from 10,816 Radiology clinics & hospitals monitored worldwide, followed by Palo Alto Medical Foundation - Radiology (3.89) and the Washington Hospital - Ultrasound Imaging (3.73).
CloseCareGap is an approved Patient Safety Organization (PSO). Using the award winning clinicalMessage ePlatform, staff can use smart tools to help measure best practice and reduce variations in care delivery at the bedside. The basic PSO toolkit is FREE and can be implemented with a few short clicks via a secure online portal. We have adopted the “IHI Leadership, Support and Care Processes” as critical areas to focus on closing gaps in care using a Continuous Learning Improvement Platform. For more information, go to http://www.clinicalmessage.org
Hello Bacsi thuộc tập đoàn Hello Health, được thành lập vào năm 2015 tại Việt Nam. Với mục tiêu trở thành đơn vị tiên phong cung cấp các thông tin về y tế được kiểm chứng bởi chuyên gia, Hello Health hiện đã có mặt tại 9 thị trường phát triển nhanh ở Châu Á với 10 nền tảng mang ngôn ngữ địa phương.
Hello Bacsi không chỉ là nền tảng cung cấp các thông tin y tế uy tín mà còn là đơn vị cung cấp các giải pháp Digital Marketing cho các doanh nghiệp hoạt động trong lĩnh vực chăm sóc sức khoẻ. Bằng nền tảng hiện có cùng với các giải pháp chất lượng cho mạng lưới khách hàng của mình, Hello Bacsi đang dần khẳng định vị thế là đơn vị tiên phong về giải pháp truyền thông, quảng cáo cho các doanh nghiệp ngành chăm sóc sức khoẻ trong thời đại công nghệ số.
Working with Regulators: A Focus on CMS | Took Kit: A Guide for Patient AdocatesCancerSupportComm
The Affordable Care Act (ACA) is the tip of a very large, multi-faceted iceberg, one that is moving inexorably forward and will result in broad, deep changes in the way that health care in this country is understood and delivered. These changes are already exerting a significant impact on cancer research and care, and will continue to do so for the foreseeable future. This is also an era in which the patient voice and genuine, active patient participation have become integral to the process of developing and implementing biomedical research and health care policy.
That process is complex and multidimensional—but also well defined and transparent. The ability to influence the outcomes requires that an organization have a working knowledge of how the process works, which agencies are responsible and who makes the decisions. It is also critical to understand the ways in which electoral politics at both the national and state level impact health care policy. While that sounds straightforward, the regulatory process often can appear impenetrable to the organizations who seek to make their voices heard and influence the outcomes.
This Tool Kit is intended as a practical guide for patient advocacy organizations in their efforts to educate themselves about the regulatory process, develop appropriate staff expertise and responsibility for this area, and ultimately make a difference.
Pathways to Patient Engagement: Insights from the Physician CommunityKathleen Poulos
Pathways to Patient Engagement: Insights from the Physician Community
Pathways to Patient Engagement is a webinar series designed to foster collaboration and discussion between all involved in the healthcare process.
During the initial webinar we explored physician insights and found 40% of those surveyed were not participating in any patient engagement activities. In fact, some of the surveyed physicians stated they were not familiar with the term patient engagement.
Review the deck as we share feedback from primary care physicians and provide resources to help all involved along the pathway to patient engagement.
Avident Health created by doctors to allow better teamwork in healthcare and to engage and educate patients. More teamwork leads to value: Better quality at lower cost.
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...MedStatix, LLC
Improving Patient Experience. Improving Practice Performance.
MedStatix, LLC, offers a WHITE LABELED, cloud-based specialty-specific patient experience survey platform that is bundled and/or resold by leading EMR/EHRs and other integrated healthcare service providers as a value-add to their products.
The patient experience platform uses data science and predictive analytics learned from data hosted on the platform to enable healthcare providers to improve quality of care, patient retention rates and risk profiles of physician practices.
The patient experience platform pinpoints specific, actionable problems where practices can improve their service through its easy-to-implement, yet sophisticated technology solution for monitoring and measuring patient experience by each provider across an organization.
With over a decade delivering over one million patient surveys for over 25 pharmaceutical brands, as well as customer feedback platforms and analytics for Fortune-class brands, MedStatix enables their resellers to provide their customers with exceptional practice improvement opportunities.
Defining What is Value-Based Care for Patients with Relapsed/Refractory Chro...Carevive
The target audiences for these activities are hematologists, medical oncologists, pulmonologists, pathologists, physician assistants, nurse practitioners, registered nurses, oncology nurses, nurse navigators, palliative/symptom management teams who care for patients with chronic lymphocytic leukemia (CLL) and quality administrators responsible for their cancer center’s adherence to value-based care delivery models.
What do MDs think about patient engagement? What's the gap between today's healthcare marketplace and the marketplace of the future? What is pathway to patient engagement?
Join us for our 4-part webinar series with the latest real time market intelligence on patient engagement.
Presentation at national SHSMD Conference in Chicago, 2010. Jeff Segall and Marcus Gordon discuss the roles on their organizations in marketing to consumers versus physicians with examples of integrated marketing campaigns.
What is Dupuytren’s Disease?
• Benign thickening and shortening of the palmar fascia
leading to digital contractures
• Early phase with nodule and cord development,
skin retraction
• Late phase with formation of contracture
Who gets Dupuytren’s disease?
• Genetic predisposition
– Especially in those of Northern European origin – Males > Females
• Age
– Wide range
– Increases with age
– Average age of onset 50 – 70 years • Occurrence
– Common
Adaptive Radiotherapy at GenesisCare UKGenesisCareUK
A discussion about adaptive radiation therapy, a closed-loop radiation treatment process and how it can improve radiation treatment by systematically monitoring treatment variations and incorporating them to re-optimize the treatment plan early on during the course of treatment.
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...GenesisCareUK
A program that seeks to redefine best practice across the drivers of the GenesisCare business (Quality, Access and Efficiency) in order to deliver on their vision of “Innovating Healthcare. Transforming Lives.”
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical Systems
1. GenesisCare UK: Varian Medical Systems
360 OncologyTM Cancer Care Coordination suite:
Collaborative development programme
Matt Hickey – Director of Clinical Strategy. GenesisCare UK
2. My participation in this Event does not interfere with any other obligations I have undertaken, in particular in connection with my current employment (if any) and that my
institution has no objections to my participation in the Event.
I acknowledge that I have no imposing duty or obligation to refer to the institution or any other health care organization, patient, or physician to any health care institution
or provider supplied by GenesisCare or its affiliates or to endorse or recommend the ordering or purchasing of any product or service of GenesisCare or its affiliates.
I hereby certify that I will comply with all applicable provisions of law and other rules and regulations of any and all governmental authorities in performing my obligations
under my Speaker Letter Agreement, as well as GenesisCare’s own ethics codes and policies, and that I have been furnished with copies of the relevant GenesisCare codes
and policies. I hereby agree that my will at all times fully cooperate with GenesisCare in meeting its obligations thereunder and that my will be bound by the ethical
principles underlying such regulations.
I further agree to keep strictly secret all confidential information of GenesisCare or its affiliates which I learn during the Event. I will perform all services in compliance with
applicable laws and regulations and apply my best efforts to the performance of the services.
I also grant GenesisCare permission to use my speech of presentation in other capacities within the Scope of Work. I also authorize and license GenesisCare to reproduce or
distribute the materials used in the Scope of Work via the GenesisCare websites. GenesisCare shall maintain the appropriate attribution to Speaker. GenesisCare may modify
the materials however, any modification of statements of Speaker that would fundamentally distort the meaning of Speaker’s statements are not authorized by this
authorization and license. This authorisation and license shall be for the purpose of advertising, promotion of marketing of GenesisCare and its products and services, and
for any other purpose that is in the spirit of the original Scope of Work. For example, the presentation or speech may be recorded, taped, captured via “LiveMeeting” and
may be added to the GenesisCare website.
To the extent that it has not been previously collected, GenesisCare may require collecting certain personal data from my like my name and email address. GenesisCare will
do so only for the purposes required under this Letter Agreement, and always in compliance with applicable law. We will only transfer my data to GenesisCare affiliates, to
the extent necessary for the fulfilment of this Letter Agreement, and specifically, to Genesis Care UK Limited, Wilson House, Waterberry Drive, Waterlooville, Hampshire ,
PO7 7XX and my hereby consent to such transfer to the extent that it is done solely for the purposes of this Letter Agreement and in compliance with applicable law.
I also acknowledge that my are an independent contractor, subject to GenesisCare’s direction only as to specific interests where GenesisCare wants the benefit of my
services and advice. Nothing in this Speaker Letter Agreement makes my an employee or agent of GenesisCare, or authorises Speaker to speak for, represent or obligate
GenesisCare in any way.
Disclosure
3. A lack of control on patient outcomes post treatment
• Global survivorship league tables paint a grim picture – not the whole story!
• After-effects are ‘post-treatment’ - Lack of ‘holistic’ surveillance - reactive care not proactive
Poor harnessing of the collective knowledge of our clinicians
• Best practice not being applied consistently
Disproportionate funding
• Chemo = 2% of cures, RT = 16% (40% combined therapy)
• Lack of public & private outcomes visibility
Commissioner mandates
• Demand for transparency
• New quality mandates
Cancer funds are under threat
• Cost of cancer treatment increasing (£7.6bn = -£17.6bn) - True cost of cancer unknown
• True benefits of innovation unknown (DFS v PFS v OS v HQoL)
SOME CANCER SERVICE CHALLENGES
4. COMPLEXITY OF INTEGRATING THE CARE CONTINUUM
SURVIVORSHIP
SCREENING CHEMOTHERAPY
Explosion of data in
disparate data sources
Is the correct pathway being
followed?
Need to see patient’s imaging
and treatment history in one place
Inefficient care
team collaboration
DIAGNOSIS RADIATIONSURGERY FOLLOW-UP
RECURRENCE
Loss of control of outcomes
post treatment
Late, incorrect diagnosis
5. GenesisCare UK Aim
“In line with our visions and
values, our goal is to ensure each
patient receives a personalised,
evidence-based care plan that
achieves the best possible
outcomes, during and beyond
treatment”
CANCER CARE COORDINATION
8. GenesisCare UK Aim
“In line with our visions and values, our goal is to
ensure each patient receives a personalised, evidence-
based care plan that achieves the best possible
outcomes, during and beyond treatment”
12. Full in-clinic and external
MDT engagement
Patient support design
PROMs & PREMs publishing,
surveillance and management
Access Clinical Insights
Seamless Workflow
Integration
Supportive care and survivorship
planning and management
13. Full in-clinic and external
MDT engagement
Patient support design
PROMs & PREMs publishing,
surveillance and management
Access Clinical Insights
Seamless Workflow
Integration
Supportive care and survivorship
planning and management
14. Dynamic patient-specific
insights at the point of care
Context-sensitive (PROMs/
PREMs, personalised)
Predictive & rapid learning
consequence of treatment modeling
Treatment Data Analytics
Clinical and Operational
dashboards
Data-driven insights
15. Dynamic patient-specific
insights at the point of care
Context-sensitive (PROMs/
PREMs, personalised)
Predictive & rapid , consequence
of treatment modeling
Treatment Data Analytics
Clinical and Operational
dashboards
Data-driven insights
18. Integrate patient values,
needs, preferences
Patient Reported Outcomes
& Patient Satisfaction
Survivorship
Patient support via mobile
platform
Patient participation in
treatment decisions
Meaningful patient engagement:
Patient engagement portal
PROM; Hybrid of
c35 PROMs Qs
highlighting key
symptoms present
in patient
presentations for
support
PREM; Hybrid of
NHS, GMC,
GenesisCare
Australia
(multi-stakeholder
benchmarking)
19. Integrate patient values,
needs, preferences
Patient Reported Outcomes
& Patient Satisfaction
Survivorship
Patient support via mobile
platform
Patient participation in
treatment decisions
Meaningful patient engagement:
Patient engagement portal
20. TRANSITION OF CARE
Episode of Care Summary: Referring Physicians, Local Care
Team, Dieticians, Social Workers, …
Full charting capability
Automated summary (Txt,
RTOG, PROMs etc)
Survivorship plan
Toxicity profile, co-morbidity
risk, monitoring plan
Patient participation in
treatment decisions
Taking
cumbersome
manual forms
with incomplete
information
21. TRANSITION OF CARE
Episode of Care Summary: Referring Physicians, Local Care
Team, Dieticians, Social Workers, …
Full charting capability
Automated summary (Txt,
RTOG, PROMs etc)
Survivorship plan
Toxicity profile, co-morbidity
risk, monitoring plan
Patient participation in
treatment decisions
Automated,
categorised and
proactive,
forms
23. Industry standardised
clinical datasets
Benchmarked patient reported
outcomes / satisfaction
Rapid Learning & Predictive
Modeling Tools
Treatment Data Analytics
Clinical and Operational
dashboards
Data-driven insights
24. Industry standardised
clinical datasets
Benchmarked patient reported
outcomes / satisfaction
Rapid Learning & Predictive
Modeling Tools
Consequence of treatment
analytics
Clinical and Operational
dashboards
Data-driven insights
25. Industry standardised
clinical datasets
Benchmarked patient reported
outcomes / satisfaction
Rapid Learning & Predictive
Modeling Tools
Treatment Data Analytics
Clinical and Operational
dashboards
Data-driven insights
26. Industry standardised
clinical datasets
Benchmarked patient reported
outcomes / satisfaction
Rapid Learning, Predictive
Modeling & correlation tools
Treatment Data Analytics
Clinical and Operational
dashboards
Data-driven insights – Dynamic
knowledgebase
27. Activated Patients
• Shared decision making with clinicians.
• Supported transition into post-treatment life.
• Optimised personal experiences directly informing therapeutic rationale - brand improvement
and return to source (GenesisCare)
Empowered Clinicians
• Dynamic decision aids to identify emerging risks and trends (+/-)
• Timely access to quality, integrated information.
• Improved shared decision making with patients for optimal treatment and long term planning
– clinicians preferentially refer
Informed Commissioners
• Transparent quality information for targeted cost-effective commissioning decision making
from preferred providers
• Primary care providers are more empowered to provide preventive care and refer to source
GCUK Cancer Care Coordination: Benefits
28. Activated communities and society
• Lower costs of morbidity.
• Improved workplace productivity
• Activated patients and empowered carers - socio-economic/ socio-political benefit
Validated research & development
• Informed R&D funding
• Better post-market release surveillance
• Patient experience reflected in public: private investment decisions
GCUK Cancer Care Coordination: Benefits
29. CHALLENGES
• GenesisCare OIS: Elekta Mosaiq
• Third-party Patient Insights, Decision Support and late-effects predictive modelling suite
• UK installation – US support
• Technical teams with difference skills (gaps)
• Limited IT & technical skills & resources in UK
RESULTS (12mths, Sept 2015-16)
Feb 9: System locally installed (4 sites, Ox, MK, Maidstone, Southampton)
Mar 12: Mosaiq mapped – IT infrastructure, hosting and cloud
June 26: Technical testing complete - System went clinically live (pilot)
Aug 12: Prostate and Breast cancer patients now being inducted
10 Sept: Clinical feature acceptance clinicians now being finalised (11 Dec 2016)
16 Oct: GenesisCare Clinical Collaborative, Brisbane – first RT clinical support officer experience
24 Oct ASTRO, Boston. Varian commercial release
12 Nov: GenesisCare UK Clinical Conference – first patient experience presentation
Delivery challenges and results
30. Varian Core project team:
• Sukhveer Singh (Sponsor): Vice President, Varian
• Roman Wicha (Project Lead)
• Shridhar Parvatikar (Technical Lead)
• Gunther Lenz (Director, OCS Technology Office)
• Steve Laws (Project Coordinator)
• Saurabha Bhatia (Snr Product Manager)
• Julien Chergui: (Insightive Lead)
GenesisCare team
• Eleanor Love (Project lead)
• Thomas Pinn (International CIO)
• Delos Wilbur (UK IT)
• Gary Bee & Dave Wastall (UK) technical support
• Fraser Hughes (Australia) (Technical support)
• GenesisCare UK Staff, Clinicians & PATIENTS
Acknowledgements
Innovation
Collaboration
for a
Quality Outcome
With 360 Oncology we focussed on addressing the discontinues in cancer care. We do this by bringing the information about the patient together from multiple information sources to create a 360 degree view of the patient care.
We have created powerful tools to make it easier for the care team to manage their tasks and commmunciate with each other to ensure care coordination.
The care coordination tools spans the entrie continuum starting with referral management, care delivery, navigation, follow up and survivorship.
We are inetgrating clinical pathways into the platform so that the entire team can play from the same song sheet.
Optimizing these delivery features for a disease as complicated and heterogeneous as cancer often entails complex decision making, multiple handoffs between primary and specialty care providers, and coordination among cancer care team members. (Ref: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119205/)
Continuing geographic, financial and social barriers prevent patients from seeking and receiving multidisciplinary care planning and comprehensive cancer care ( Spinks et. Al 2012)
No where else is it more critical to bring the key information and decision make than the tumor boards. Making the right treatment choice is the most critical step in cancer. Care.
I truly believe that 360 Oncology Tumor board application will truly transform the way tumor boards are prepared for and conducted. It will replace the current cumbersome processes to
Make it seamless to gather all the evidence data needed for the tumor board
Simply tumor board workflow manage including management of the tumor boarding
Imagine a few simple clicks to add patients to the tumor board including the relevant information.
Intutibve and simple way to review patient cases during the tumor baord
Ease of documenting the decision.
Easy access to decsion support tools and clinical insights relevant to the clinical context for the patient/
I am amazed at what the team has been accomplish this application.
That’s how 360 Oncology will allow you make decisions confidently.
No where else is it more critical to bring the key information and decision make than the tumor boards. Making the right treatment choice is the most critical step in cancer. Care.
I truly believe that 360 Oncology Tumor board application will truly transform the way tumor boards are prepared for and conducted. It will replace the current cumbersome processes to
Make it seamless to gather all the evidence data needed for the tumor board
Simply tumor board workflow manage including management of the tumor boarding
Imagine a few simple clicks to add patients to the tumor board including the relevant information.
Intutibve and simple way to review patient cases during the tumor baord
Ease of documenting the decision.
Easy access to decsion support tools and clinical insights relevant to the clinical context for the patient/
I am amazed at what the team has been accomplish this application.
That’s how 360 Oncology will allow you make decisions confidently.
No where else is it more critical to bring the key information and decision make than the tumor boards. Making the right treatment choice is the most critical step in cancer. Care.
I truly believe that 360 Oncology Tumor board application will truly transform the way tumor boards are prepared for and conducted. It will replace the current cumbersome processes to
Make it seamless to gather all the evidence data needed for the tumor board
Simply tumor board workflow manage including management of the tumor boarding
Imagine a few simple clicks to add patients to the tumor board including the relevant information.
Intutibve and simple way to review patient cases during the tumor baord
Ease of documenting the decision.
Easy access to decsion support tools and clinical insights relevant to the clinical context for the patient/
I am amazed at what the team has been accomplish this application.
That’s how 360 Oncology will allow you make decisions confidently.
Last but not least, 360 oncology is designed to provide data driven insights at every step of the way.
The beauty of integrating workflow and analtycis is that 360 Onclogu brings the insights to you where they are needed and in the context they are needed.
We also enabling access to an array of context sensitive and predictive decision support tools.
The analytics capabilities of 360 degree include clinical as well as operational tools
The costs of direct medical care for cancer are estimated to account for 5 percent of national health care spending (Sullivan et al.,2011)
One large insurer, United Health care estimated that 11 percent of its costs are for cancer care (IOM,2013)
Cancer care costs are highest in the months following a cancer diagnosis and at the end of life (Yabroff et al.,2011)
Last but not least, 360 oncology is designed to provide data driven insights at every step of the way.
The beauty of integrating workflow and analtycis is that 360 Onclogu brings the insights to you where they are needed and in the context they are needed.
We also enabling access to an array of context sensitive and predictive decision support tools.
The analytics capabilities of 360 degree include clinical as well as operational tools
The costs of direct medical care for cancer are estimated to account for 5 percent of national health care spending (Sullivan et al.,2011)
One large insurer, United Health care estimated that 11 percent of its costs are for cancer care (IOM,2013)
Cancer care costs are highest in the months following a cancer diagnosis and at the end of life (Yabroff et al.,2011)
Research indicates that when patients are involved in their own care, they are more satisfied with the care they receive and often experience better health outcomes (Alston et al., 2012;CFAH,2010;Hibbard and Greene 2013)
Decision aids are one mechanism that can help improve patient’s understanding of their prognosis, their treatment options and the benefits and harms of treatment (Leigh et al.,2011)
Studies have found that clinicians ask for patient preferences in medical decisions only about half the time (Lee et al., 2012; Zikmund-Fisher et al., 2010).
Limitation of the current evidence base is that it frequently does not capture information about the impact of a treatment regimen on quality of life, functional and cognitive status, symptoms and overall patient experience with the disease (IOM 2013)
Reminder systems triggered from data in patients’ EHRs can lead to patients’ improved adherence to treatment protocols and screening recommendations (Din et al., 2005; Nease et al., 2008; Sequist et al., 2009; Shea et al., 1996).
In a study where patients were invited to read their clinicians’ notes, patients accessed their EHRs regularly and reported that this was a positive experience; the clinicians reported this had a minimal impact on their workflow (Delbanco et al. 2012).
Research indicates that when patients are involved in their own care, they are more satisfied with the care they receive and often experience better health outcomes (Alston et al., 2012;CFAH,2010;Hibbard and Greene 2013)
Decision aids are one mechanism that can help improve patient’s understanding of their prognosis, their treatment options and the benefits and harms of treatment (Leigh et al.,2011)
Studies have found that clinicians ask for patient preferences in medical decisions only about half the time (Lee et al., 2012; Zikmund-Fisher et al., 2010).
Limitation of the current evidence base is that it frequently does not capture information about the impact of a treatment regimen on quality of life, functional and cognitive status, symptoms and overall patient experience with the disease (IOM 2013)
Reminder systems triggered from data in patients’ EHRs can lead to patients’ improved adherence to treatment protocols and screening recommendations (Din et al., 2005; Nease et al., 2008; Sequist et al., 2009; Shea et al., 1996).
In a study where patients were invited to read their clinicians’ notes, patients accessed their EHRs regularly and reported that this was a positive experience; the clinicians reported this had a minimal impact on their workflow (Delbanco et al. 2012).
Research indicates that when patients are involved in their own care, they are more satisfied with the care they receive and often experience better health outcomes (Alston et al., 2012;CFAH,2010;Hibbard and Greene 2013)
Decision aids are one mechanism that can help improve patient’s understanding of their prognosis, their treatment options and the benefits and harms of treatment (Leigh et al.,2011)
Studies have found that clinicians ask for patient preferences in medical decisions only about half the time (Lee et al., 2012; Zikmund-Fisher et al., 2010).
Limitation of the current evidence base is that it frequently does not capture information about the impact of a treatment regimen on quality of life, functional and cognitive status, symptoms and overall patient experience with the disease (IOM 2013)
Reminder systems triggered from data in patients’ EHRs can lead to patients’ improved adherence to treatment protocols and screening recommendations (Din et al., 2005; Nease et al., 2008; Sequist et al., 2009; Shea et al., 1996).
In a study where patients were invited to read their clinicians’ notes, patients accessed their EHRs regularly and reported that this was a positive experience; the clinicians reported this had a minimal impact on their workflow (Delbanco et al. 2012).
Last but not least, 360 oncology is designed to provide data driven insights at every step of the way.
The beauty of integrating workflow and analtycis is that 360 Onclogu brings the insights to you where they are needed and in the context they are needed.
We also enabling access to an array of context sensitive and predictive decision support tools.
The analytics capabilities of 360 degree include clinical as well as operational tools
The costs of direct medical care for cancer are estimated to account for 5 percent of national health care spending (Sullivan et al.,2011)
One large insurer, United Health care estimated that 11 percent of its costs are for cancer care (IOM,2013)
Cancer care costs are highest in the months following a cancer diagnosis and at the end of life (Yabroff et al.,2011)
Last but not least, 360 oncology is designed to provide data driven insights at every step of the way.
The beauty of integrating workflow and analtycis is that 360 Onclogu brings the insights to you where they are needed and in the context they are needed.
We also enabling access to an array of context sensitive and predictive decision support tools.
The analytics capabilities of 360 degree include clinical as well as operational tools
The costs of direct medical care for cancer are estimated to account for 5 percent of national health care spending (Sullivan et al.,2011)
One large insurer, United Health care estimated that 11 percent of its costs are for cancer care (IOM,2013)
Cancer care costs are highest in the months following a cancer diagnosis and at the end of life (Yabroff et al.,2011)
Last but not least, 360 oncology is designed to provide data driven insights at every step of the way.
The beauty of integrating workflow and analtycis is that 360 Onclogu brings the insights to you where they are needed and in the context they are needed.
We also enabling access to an array of context sensitive and predictive decision support tools.
The analytics capabilities of 360 degree include clinical as well as operational tools
The costs of direct medical care for cancer are estimated to account for 5 percent of national health care spending (Sullivan et al.,2011)
One large insurer, United Health care estimated that 11 percent of its costs are for cancer care (IOM,2013)
Cancer care costs are highest in the months following a cancer diagnosis and at the end of life (Yabroff et al.,2011)
Last but not least, 360 oncology is designed to provide data driven insights at every step of the way.
The beauty of integrating workflow and analtycis is that 360 Onclogu brings the insights to you where they are needed and in the context they are needed.
We also enabling access to an array of context sensitive and predictive decision support tools.
The analytics capabilities of 360 degree include clinical as well as operational tools
The costs of direct medical care for cancer are estimated to account for 5 percent of national health care spending (Sullivan et al.,2011)
One large insurer, United Health care estimated that 11 percent of its costs are for cancer care (IOM,2013)
Cancer care costs are highest in the months following a cancer diagnosis and at the end of life (Yabroff et al.,2011)